Vr Adviser, LLC Adverum Biotechnologies, Inc. Transaction History

Vr Adviser, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.26 $1.07 Million - $1.8 Million	-1,425,753 Reduced 21.69%	5,147,547 $3.86 Million
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.33 $4.03 Million - $6.26 Million	2,687,054 Added 69.14%	6,573,300 $9.86 Million
Q2 2023 Aug 11, 2023	BUY	$0.68 - $1.59 $2.64 Million - $6.18 Million	3,886,246 New	3,886,246 $6.18 Million
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $8.48 Million - $25.5 Million	-994,381 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $7.94 Million - $16.2 Million	994,381 New	994,381 $9.72 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.